Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey.  Saloner B, Krawczyk N, Solomon K, Allen ST, Morris M, Haney K, Sherman SG.  Int J Drug Policy. 2021 Nov 19;101:103537. do…

The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic.  Nesoff ED, Marziali ME, Martins SS.  Addiction. 2021 Dec 7. doi: 10.1111/add.15778. Epub ahead of print…

Irland. Large numbers of people with drug addictions were 'left to kill themselves slowly' during lockdowns Substance abuse support groups were closed for five months in 2020 – with catastrophic impacts for the people who attend them. (The Journal…

Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program.  Harris R, Rosecrans A, Zoltick M, Willman C, Saxton R, Cotterell M, Bell J, Blackwell I, Page KR.  Drug Alcohol Depend. 2022 Jan 1;…

COVID-19-related adaptations to the implementation and evaluation of a clinic-based intervention designed to improve opioid safety.  Morgan AR, Hendricks MA, El Ibrahimi S, Hallvik SE, Hatch B, Dickinson C, Wright D, Fischer MA.  Drugs C…

Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19.  Samuels EA, Khatri UG, Snyder H, Wightman RS, Tofighi B, Krawczyk N.  J Gen Intern Med. 2022 Jan 3:1–3. doi: 10.1007/s11606-021-07249-8. Epub ahead of print. P…